| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/29/2010 | EP2231282A1 Protein kinase inhibitors and use thereof |
| 09/29/2010 | EP2231281A2 Combination comprising a mek inhibitor and an aurora kinase inhibitor |
| 09/29/2010 | EP2231193A1 Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance |
| 09/29/2010 | EP2231192A1 Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance |
| 09/29/2010 | EP2231189A1 Drug delivery system for administration of poorly water soluble pharmaceutically active substances |
| 09/29/2010 | EP2231188A2 Use of 5-aminolevulinic acid and derivatives in a solid form for photodynamic treatment and diagnosis |
| 09/29/2010 | EP2231187A1 Method of inhibition of leukemic stem cells |
| 09/29/2010 | EP2231185A1 Methods and compositions for treating liquid tumors |
| 09/29/2010 | EP2231166A1 Medium-chain length fatty acids, salts and triglycerides in combination with gemcitabine for treatment of pancreatic cancer |
| 09/29/2010 | EP2231161A1 A process of making imatinib |
| 09/29/2010 | EP2231156A1 Methods for increasing white blood cells |
| 09/29/2010 | EP2231152A2 Thienopyranones as kinase inhibitors |
| 09/29/2010 | EP2231151A2 Antifolate compounds for the treatment of melanoma |
| 09/29/2010 | EP2231140A1 Sigma ligands and ikk / nf - kb inhibitors for medical treatment |
| 09/29/2010 | EP2231133A2 Method and compositions for administering resveratrol and pterostilbene |
| 09/29/2010 | EP2231132A2 Method for preparing nanoparticles based on functional amphiphilic molecules or macromolecules, and the use thereof |
| 09/29/2010 | EP2099797B1 Compounds and compositions as protein kinase inhibitors |
| 09/29/2010 | EP2044058B1 Chemical compounds |
| 09/29/2010 | EP1929034B1 Cancerous disease modifying antibodies |
| 09/29/2010 | EP1904490B1 Ethanolamine salt of n- (3-methoxy-5-methylpyrazin-2yl) -2- (4- [1 , 3 , 4-0xadiaz0le-2-yl]phenyl) pyridine-3- sulphonamide |
| 09/29/2010 | EP1768979B1 Octahydropyrrolo[2, 3, c]pyridine derivatives and pharmaceutical use thereof |
| 09/29/2010 | EP1729803B1 Therapeutic use of anti-cs1 antibodies |
| 09/29/2010 | EP1727817B1 Azabicyclooctan-3-one derivatives and use thereof |
| 09/29/2010 | EP1628957B1 Sulfopyrroles |
| 09/29/2010 | EP1534695B1 Tyrosine kinase inhibitors |
| 09/29/2010 | EP1476120B1 Treatment methods using anti-cd22 antibodies |
| 09/29/2010 | EP1450847B1 APO2 ligand/ TRAIL formulations and uses thereof |
| 09/29/2010 | EP1446136B1 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 09/29/2010 | EP1421074B1 Novel compounds |
| 09/29/2010 | EP1399411B1 Aloe-emodin derivatives and their use in the treatment of neoplastic pathologies |
| 09/29/2010 | EP1095274B1 Trifunctional reagent for conjugation to a biomolecule |
| 09/29/2010 | CN1893963B Production of hop extracts having oestrogenic and antiproliferative bioactivity |
| 09/29/2010 | CN1882569B 喹唑啉衍生物 Quinazoline derivatives |
| 09/29/2010 | CN1739577B Cancer treating Chinese medicine preparation |
| 09/29/2010 | CN101849014A Chimeric PUFA polyketide synthase systems and uses thereof |
| 09/29/2010 | CN101849007A RNA antagonist compounds for the modulation of HER3 |
| 09/29/2010 | CN101848999A Anti-CD20 monoclonal antibodies |
| 09/29/2010 | CN101848998A Anti-EPHA2 antibody |
| 09/29/2010 | CN101848909A Pyrrolo(3,2-C) pyridines useful as inhibitors of protein kinases |
| 09/29/2010 | CN101848898A Phthalazinone derivatives as inhibitors of PARP-1 |
| 09/29/2010 | CN101848895A Combination of anti-angiogenic substance and anti-tumor platinum complex |
| 09/29/2010 | CN101848892A Hydrobenzamide derivatives as inhibitors of HSP90 |
| 09/29/2010 | CN101848730A Capsid proteins and uses therefore |
| 09/29/2010 | CN101848728A Pharmaceutical compositions containing the enzyme cyprosin, an aspartic peptidase from cynara cardunculus and its inclusion in antitumour formulations |
| 09/29/2010 | CN101848708A Corticosteroids to treat epothilone or epothilone derivative induced diarrhea |
| 09/29/2010 | CN101845446A Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof |
| 09/29/2010 | CN101845442A Method for preparing human interleukin 28A by silkworm bioreactor and pharmaceutical application thereof |
| 09/29/2010 | CN101845438A Sensitive diagnosis and relative treatment for cancers through 20 tumor specific related genes and products |
| 09/29/2010 | CN101845075A 6-substituted-4-azepine-A-homo-3-oxosteroid compound and application thereof to preparing anti-tumor medicine |
| 09/29/2010 | CN101845060A Beta-carboline ruthenium compound as well as preparation method and application thereof |
| 09/29/2010 | CN101845051A Nitrogen-containing heterocyclic thienopyridine compounds and preparation method and application thereof |
| 09/29/2010 | CN101845033A Paramagnetic iron and selenium quercetin complex and preparation method as well as application thereof |
| 09/29/2010 | CN101845032A Phenolic compound and uses |
| 09/29/2010 | CN101845026A 5-(4-chlorophenylmethyl)-4-tertiary butyl thiazole derivatives and preparation method and application thereof |
| 09/29/2010 | CN101845009A Structural carotenoid analogs for the inhibition and amelioration of disease |
| 09/29/2010 | CN101843904A Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer |
| 09/29/2010 | CN101843898A Application of marine collagen peptide in preparing drugs, health-care foods or foods for tumor prevention and inhibition |
| 09/29/2010 | CN101843896A Recombinant human interferon alpha 2b injection with high concentration and low filling quantity |
| 09/29/2010 | CN101843895A Cytokine receptor ZCYTOR17 multimers |
| 09/29/2010 | CN101843894A Application of pumpkin protein to preparation of medicament for treating lung cancer |
| 09/29/2010 | CN101843890A Oral medicament for treating tumors through Chinese medicinal herbs |
| 09/29/2010 | CN101843876A Chinese medicinal composition for preventing renal cell apoptosis and anemia caused by cis-platinum (DDP) and preparation method thereof |
| 09/29/2010 | CN101843856A Chinese medicinal herb for treating cancer |
| 09/29/2010 | CN101843794A Chinese medicament for treating brain tumors |
| 09/29/2010 | CN101843779A Baihuawang liquid and application thereof |
| 09/29/2010 | CN101843665A Fig leaf extract lozenges |
| 09/29/2010 | CN101843663A Preparation method of extract package of volatile oil heavier than water |
| 09/29/2010 | CN101843656A External medicinal liquor for treating cancer and preparation method thereof |
| 09/29/2010 | CN101843653A Processing method of Chinese stellera root condensed decoction |
| 09/29/2010 | CN101843641A Novel adenoviruses, nucleic acids coding therefor, and use thereof |
| 09/29/2010 | CN101843633A Use of limonium sinense kuntze polysaccharose in preparation of anti-oxidizing medicament |
| 09/29/2010 | CN101843621A TS-1 granules and preparation method thereof |
| 09/29/2010 | CN101843618A Application of berberine and derivatives thereof in preparation of indole amine 2, 3-dioxygenase inhibitor |
| 09/29/2010 | CN101843611A Application of N-[4-(N-{5-[(2,3-dihydro-1H-indene-5-yloxy) methyl]-2-furyl}acethydrazide)phenyl]cyclopentane formamide in preparing anti-tumor medication |
| 09/29/2010 | CN101843605A Emodin as inhibitor of activated molecules p-Akt and p-mTOR of PI3K/Akt/mTOR signal transduction pathway and application thereof |
| 09/29/2010 | CN101843592A Preparation method of decitabine freeze-dried powder injection |
| 09/29/2010 | CN101843591A 1'-acetoxyl chavicol acetate naonparticle |
| 09/29/2010 | CN101843585A Method for preparing whole peptidoglycan magnetic liposome |
| 09/29/2010 | CN101843584A Composite of all-trans-retinoic acid and liposome and application thereof |
| 09/29/2010 | CN101843582A Taxol nanosuspension and preparation method thereof |
| 09/29/2010 | CN101843578A Nanofiber membrane carrying anti-tumor photosensitizer and preparation method thereof |
| 09/29/2010 | CN101843577A Coating implant using zein as skeleton material and preparation method |
| 09/29/2010 | CN101487022B Preparation of fermentation liquor for inhibiting liver cancer cell growth |
| 09/29/2010 | CN101450035B Double sustained release biological agent for tumor local ablation therapy |
| 09/29/2010 | CN101427998B Astragalus polysaccharide calcium phosphate nano-paclitaxel composite injection, and preparation method |
| 09/29/2010 | CN101422483B Medicine for suppressing breast cancer cell in-vitro growth and treating breast cancer |
| 09/29/2010 | CN101406455B Strychnine composite phospholipid liposome, and preparation method thereof and use in pharmacy |
| 09/29/2010 | CN101342271B Traditional Chinese medicine for treating qi-blood deficiency caused by tumour chemotherapy and preparation method thereof |
| 09/29/2010 | CN101337931B Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)amino-phenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these |
| 09/29/2010 | CN101336917B Use of annonaceous acetogenins in preparing medicine for treating lung cancer or breast cancer |
| 09/29/2010 | CN101317845B Pharmaceutical use of 6-aryl substituted pyridine compounds |
| 09/29/2010 | CN101314041B Medicine carrying system of polymer micelle and preparation method thereof |
| 09/29/2010 | CN101264178B Preparation of Chinese medicine lotion for treating malignant skin ulcer |
| 09/29/2010 | CN101250236B Tuckahoe dextran phosphate esterified derivative as well as preparation and use thereof |
| 09/29/2010 | CN101234204B High molecule bonding adriamycin medicine, nano capsule and preparation thereof |
| 09/29/2010 | CN101229348B Chinese traditional medicine compounds for treating tumour and preparing method thereof |
| 09/29/2010 | CN101229335B Enzyme method for preparing smilax scobinicaulis total saponin extract |
| 09/29/2010 | CN101224307B Acute progranulocyte leukemia DNA vaccine PML-RAR alpha 384-hIL-2 and preparing method and application thereof |
| 09/29/2010 | CN101215561B MiR-181a antisense oligonucleotide with leukemia resisting action and application thereof |
| 09/29/2010 | CN101215560B MiR-21 antisense oligonucleotide with leukemia resisting action and application thereof |